Allergy Treatment Market Size to Reach USD 36.2 Billion by 2032, Growing at a 5.8% CAGR

SAN FRANCISCO - July 29, 2026 - PRLog -- Allergy Treatment Market Growth Driven by Rising Demand for Effective Therapies

Global Allergy Treatment Market was valued at USD 20.8 billion in 2022 and is forecast to reach USD 36.2 billion by 2032, registering a compound annual growth rate (CAGR) of 5.8% during the forecast period. Market continues to gain momentum as healthcare providers increasingly focus on improving allergy diagnosis, expanding access to innovative treatments, and enhancing patient outcomes.

Growing awareness of allergic disorders, coupled with continuous advancements in treatment options, is supporting sustained market expansion across developed and emerging economies.

Telemedicine Emerges as a Key Allergy Treatment Market Trend

One of the most significant Allergy Treatment Market trends is the rapid adoption of telemedicine for allergy consultations, follow-up care, and prescription management. Digital healthcare platforms are improving access to allergy specialists while enabling convenient remote monitoring and personalised treatment plans. This trend is expected to strengthen market growth throughout the forecast period.

North America Leads While Asia-Pacific Records Strong Growth

North America accounted for the largest share of the Allergy Treatment Market, generating more than USD 8.1 billion in revenue in 2022. The region benefits from advanced healthcare infrastructure, higher awareness of allergic diseases, and widespread availability of allergy treatment options.

Meanwhile, the Asia-Pacific Allergy Treatment Market is expected to witness the fastest expansion, registering a CAGR of around 6% between 2023 and 2032. Rising healthcare investments, increasing urbanisation, and growing awareness of allergy management continue to create significant growth opportunities across the region.

Access PDF Sample Report: https://ln.run/RINqE

Rhinitis and Anti-Allergy Drugs Continue to Dominate

By type, the rhinitis segment accounted for approximately 41% of the global market share in 2022, highlighting the high prevalence of allergic rhinitis and increasing demand for effective therapeutic solutions.

Based on treatment type, the anti-allergy drugs segment generated more than USD 4.4 billion in revenue in 2022, supported by the widespread use of antihistamines and other pharmaceutical therapies for managing allergy symptoms.

Market Outlook

Allergy Treatment Market is expected to maintain steady growth through 2032 as healthcare systems continue to invest in innovative therapies, digital healthcare solutions, and improved patient access to treatment. Increasing disease awareness, expanding treatment availability, and technological advancements are anticipated to further strengthen the market outlook over the coming decade.

Read full news at Globenewswire: https://www.globenewswire.com/news-release/2023/04/11/2644650/0/en/allergy-treatment-market-size-growing-at-5-8-cagr-set-to-reach-usd-36-2-billion-by-2032.html